Literature DB >> 24509519

Comparison of liver SUV using unenhanced CT versus contrast-enhanced CT for attenuation correction in (18)F-FDG PET/CT.

Edwin E G W ter Voert1, Hanneke W M van Laarhoven, Peter J M Kok, Wim J G Oyen, Eric P Visser, Lioe-Fee de Geus-Oei.   

Abstract

AIM: The aim of the study was to compare standardized uptake values (SUVs) in liver tissue obtained using whole-body unenhanced low-dose computed tomography (CT) with those obtained using contrast-enhanced high-dose CT for PET attenuation correction in PET/CT scanning.
MATERIALS AND METHODS: Ten patients scheduled for (18)F-FDG PET and contrast-enhanced CT of the abdomen were included in this study. PET data were corrected for attenuation using both unenhanced low-dose CT images and contrast-enhanced high-dose CT images. Differences in SUV(mean) and SUV(max) were compared in three liver regions.
RESULTS: The average SUV(mean) and SUV(max) of all regions were 2.43 and 2.91 g/cm in the unenhanced data set and 2.53 and 3.17 g/cm in the enhanced data set, respectively.
CONCLUSION: SUV(mean) and SUV(max) were significantly elevated in liver tissue when using PET images corrected for attenuation with contrast-enhanced high-dose CT compared with PET images corrected with unenhanced low-dose CT. Although the differences may not be relevant in daily clinical practice, unenhanced and contrast-enhanced CT should not be selected randomly for attenuation correction if exact quantitative results are required.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24509519     DOI: 10.1097/MNM.0000000000000086

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  3 in total

1.  Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer.

Authors:  Linda Heijmen; Edwin E G W ter Voert; Wim J G Oyen; Cornelis J A Punt; Dick Johan van Spronsen; Arend Heerschap; Lioe-Fee de Geus-Oei; Hanneke W M van Laarhoven
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

2.  FDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CT.

Authors:  Xuan Canh Nguyen; Dinh Song Huy Nguyen; Van Tan Ngo; Simone Maurea
Journal:  Asia Ocean J Nucl Med Biol       Date:  2015

3.  SNMMI Procedure Standard/EANM Practice Guideline on Pediatric 18F-FDG PET/CT for Oncology 1.0.

Authors:  Reza Vali; Adam Alessio; Rene Balza; Lise Borgwardt; Zvi Bar-Sever; Michael Czachowski; Nina Jehanno; Lars Kurch; Neeta Pandit-Taskar; Marguerite Parisi; Arnoldo Piccardo; Victor Seghers; Barry L Shulkin; Pietro Zucchetta; Ruth Lim
Journal:  J Nucl Med       Date:  2021-01       Impact factor: 11.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.